Dose reduction of infliximab in Crohn’s disease, based on serum infliximab concentration

Update Il y a 4 ans
Reference: EUCTR2013-001029-17

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy and safety of IFX dose reduction guided by serial TL measurements, compared with usual care (no dose adjustments).


Inclusion criteria

  • Crohn’s Disease

Links